Advent of nanotechnology to positively shape the growth of the nutraceutical excipient market
Nutraceuticals,
also known as nutraceutical proteins, are food-grade versions of therapeutic
proteins commonly used in medication. These products are formed from plant
sources and are usually prepared as powders, capsules, and tablets.
Nutraceuticals have gained much popularity in recent times for their wide range
of health benefits. Nutraceuticals are pharmaceuticals that are used in the
treatment of various diseases and improve the functionality of food. Various
food ingredients and their compositions are formulated by means of the use of
nutraceutical excipients which improve the bioavailability of nutraceutical
products containing medicinal substances.
Advancement
in nanotechnology which is used to provide new functions to excipients is a
prime factor driving the growth of the nutraceutical excipient market. The
growing use of nutraceutical excipients in nutraceutical products such as
supplements, food and beverage applications is again fostering the growth of
the nutraceutical excipient market. Factor such as multiple uses of
nutraceutical excipients which includes filler, binding, diluent, coating
agent, disintegrants, and flavoring agent is further anticipated to propel the
growth of the nutraceutical
excipient market. Furthermore, expanding the food and beverage industry
around the globe due to westernization and increasing population is further
projected to augment the growth of the market.
North
America is projected to gain significant growth over the forecast period and
this is attributed to the increasing spending on the food industry in the
region. According to USDA’s Economic Research Service, in 2018 Americans spent
an average of 9.7% of their total disposable income on food at home and food
away from home. USDA indicates that $1.7 trillion was spent on total food
expenditures in the U.S. in 2018, up to $78.2 billion from the previous year.
Key Developments:
1. In October 2020, MEGGLE
Excipients & Technology has developed Reta M®. The first
hypromellose/mannitol-based, co-processed excipient specifically designed for
direct compression (DC) and dry granulation of modified release formulations
for the pharmaceutical and nutraceutical market
2. In December 2020, DKSH has signed
an exclusive distribution agreement with Omya, a global producer of
mineral-based solutions, for France and Spain. DKSH will provide marketing and
sales, distribution and logistics as well as customer management for Omya’s
portfolio of nutraceutical and pharmaceutical ingredients.
3. In September 202, Roquette, a
global provider of plant-based ingredients, a pioneer of plant proteins and a
pharmaceutical excipients, has announced Barentz as its strategic partner for
the distribution of pharmaceutical and nutraceutical products in the United
States
Comments
Post a Comment